Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration

Pharmaceutical Research

Volumn 22, Issue 6, 2005, Pages 940-950

  Luginbuehl, Vera ^a   Wenk, Esther ^a   Koch, Annette ^a   Gander, Bruno ^a   Merkle, Hans P ^a   Meinel, Lorenz ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Bone healing; Drug delivery systems; Insulin like growth factor I; Osteoinduction; Sustained drug delivery

Indexed keywords

ALGINIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE; MICROSPHERE; PHOSPHATE; POLYGLACTIN; RESOMER; SOMATOMEDIN C;

ARTICLE; BIOCOMPATIBILITY; BONE DEFECT; BONE REGENERATION; CELL ACTIVITY; CELL PROLIFERATION; COMPOSITE MATERIAL; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; GELATION; HUMAN; HUMAN CELL; HYDROGEL; IMPLANT; OSTEOBLAST; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ALGINATES; ALGORITHMS; ALKALINE PHOSPHATASE; BONE REGENERATION; CALCIUM PHOSPHATES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHYSICAL; DELAYED-ACTION PREPARATIONS; DNA; HUMANS; HYDROGELS; INSULIN-LIKE GROWTH FACTOR I; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; RHEOLOGY; STRESS, MECHANICAL;

EID: 21244483142     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-4589-9     Document Type: Article

References (46)

1. A. S. Hoffman 2002 Hydrogels for biomedical applications Adv. Drug Deliv. Rev. 54 3 12
2. B. R. Constantz I. C. Ison M. T. Fulmer R. D. Poser S. T. Smith M. VanWagoner J. Ross S. A. Goldstein J. B. Jupiter D. I. Rosenthal 1995 Skeletal repair by in situ formation of the mineral phase of bone Science 267 1796 1799
3. L. L. Hench I. D. Xynos J. M. Polak 2004 Bioactive glasses for in situ tissue regeneration J. Biomater. Sci. Polym. Ed. 15 543 562
4. J. A. Burdick M. N. Mason A. D. Hinman K. Thorne K. S. Anseth 2002 Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization J. Control. Release 83 53 63
5. R. G. Payne M. J. Yaszemski A. W. Yasko A. G. Mikos 2002 Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles Biomaterials 23 4359 4371
6. A. Gutowska B. Jeong M. Jasionowski 2001 Injectable gels for tissue engineering Anat. Rec. 263 342 349
7. S. Wee W. R. Gombotz 1998 Protein release from alginate matrices Adv. Drug Deliv. Rev. 31 267 285
8. C. K. Kuo P. X. Ma 2001 Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties Biomaterials 22 511 521
9. B. J. Spargo A. S. Rudolph F. M. Rollwagen 1994 Recruitment of tissue resident cells to hydrogel composites: in vivo response to implant materials Biomaterials 15 853 858
10. M. Otterlei K. Ostgaard G. Skjak-Braek O. Smidsrod P. Soon-Shiong T. Espevik 1991 Induction of cytokine production from human monocytes stimulated with alginate J. Immunother. 10 286 291
11. N. E. Simpson C. L. Stabler C. P. Simpson A. Sambanis I. Constantinidis 2004 The role of the CaCl2-guluronic acid interaction on alginate encapsulated betaTC3 cells Biomaterials 25 2603 2610
12. J. A. Rowley G. Madlambayan D. J. Mooney 1999 Alginate hydrogels as synthetic extracellular matrix materials Biomaterials 20 45 53
13. L. Meinel O. Illi J. Zapf M. Malfanti H. P. Merkle B. Gander 2001 Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres J. Control. Release 70 1-2 193 202
14. L. Meinel E. Zoidis J. Zapf P. Hassa M. O. Hottiger J. A. Auer R. Schneider B. Gander V. Luginbuehl R. Bettschart-Wolfisberger O. E. Illi H. P. Merkle B. von Rechenberg 2003 Localized insulin-like growth factor I delivery to enhance new bone formation Bone 33 660 672
15. L. Meinel O. E. Illi J. Zapf M. Malfanti H. Peter Merkle B. Gander 2001 Stabilizing insulin-like growth factor-I in poly(D, L-lactide-co-glycolide) microspheres J. Control. Release 70 193 202
16. H. J. Kong M. K. Smith D. J. Mooney 2003 Designing alginate hydrogels to maintain viability of immobilized cells Biomaterials 24 4023 4029
17. C. Y. M. Tung P. J. Dynes 1982 Relationship between viscoelastic properties and gelation in thermosetting systems J. Appl. Polym. Sci. 27 569 574
18. K. Matsuzaka X. F. Walboomers J. E. de Ruijter J. A. Jansen 1999 The effect of poly-L-lactic acid with parallel surface micro groove on osteoblast-like cells in vitro Biomaterials 20 1293 1301
19. D. Byrom 1991 Biomaterials Novel Materials from Biological Sources Stockton Press New York
20. D. J. McQuillan M. D. Richardson J. F. Bateman 1995 Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2) Bone 16 415 426
21. J. Clover M. Gowen 1994 Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15 585 591
22. C. Farquharson J. Milne N. Loveridge 1993 Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase Bone Miner. 22 105 115
23. K. Raile R. Hille S. Laue A. Schulz G. Pfeifer F. Horn W. Kiess 2003 Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I Horm. Metab. Res. 35 786 793
24. M. N. Pollak C. Polychronakos M. Richard 1990 Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma J. Natl. Cancer Inst. 82 301 305
25. E. Murray D. Provvedini D. Curran B. Catherwood H. Sussman S. Manolagas 1987 Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity J. Bone Miner. Res. 2 231 238
26. S. Takamizawa Y. Maehata K. Imai H. Senoo S. Sato R. Hata 2004 Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells Cell Biol. Int. 28 255 265
27. S. B. Rodan Y. Imai M. A. Thiede G. Wesolowski D. Thompson Z. Bar-Shavit S. Shull K. Mann G. A. Rodan 1987 Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties Cancer Res. 47 4961 4966
28. S. A. Goldstein D. L. Wilson D. A. Sonstegard L. S. Matthews 1983 The mechanical properties of human tibial trabecular bone as a function of metaphyseal location J. Biomech. 16 965 969
29. H. K. Koerten J. van der Meulen 1999 Degradation of calcium phosphate ceramics J. Biomed. Mater. Res. 44 78 86
30. E. Alsberg H. J. Kong Y. Hirano M. K. Smith A. Albeiruti D. J. Mooney 2003 Regulating bone formation via controlled scaffold degradation J. Dent. Res. 82 903 908
31. F. Gu B. Amsden R. Neufeld 2004 Sustained delivery of vascular endothelial growth factor with alginate beads J. Control. Release 96 463 472
32. R. J. Laham F. W. Sellke E. R. Edelman J. D. Pearlman J. A. Ware D. L. Brown J. P. Gold M. Simons 1999 Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial Circulation 100 1865 1871
33. M. L. Springer G. Hortelano D. M. Bouley J. Wong P. E. Kraft H. M. Blau 2000 Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor J. Gene Med. 2 279 288
34. M. L. Springer T. K. Ip H. M. Blau 2000 Angiogenesis monitored by perfusion with a space-filling microbead suspension Molec. Ther. 1 82 87
35. M. C. Peters B. C. Isenberg J. A. Rowley D. J. Mooney 1998 Release from alginate enhances the biological activity of vascular endothelial growth factor J. Biomater. Sci., Polym. Ed. 9 1267 1278
36. Y. M. Elcin V. Dixit G. Gitnick 2001 Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing Artif. Organs 25 558 565
37. M. E. Svoboda J. J. van Wyk D. G. Klapper R. E. Fellows F. E. Grissom R. J. Schlueter 1980 Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins Biochemistry 19 790 797
38. J. Zapf E. Schoenle E. R. Froesch 1978 Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum Eur. J. Biochem. 87 285 296
39. A. Haug 1964 Composition and Properties of Alginates Norwegian Institute of Technology Trondheim
40. D. Malamud J. Drysdale 1978 Isoelectric points of proteins: a table Anal. Biochem. 86 620 647
41. D. S. Steinbrech B. J. Mehrara N. M. Rowe M. E. Dudziak P. B. Saadeh G. K. Gittes M. T. Longaker 1999 Gene expression of insulin-like growth factors I and II in rat membranous osteotomy healing Ann. Plast. Surg. 42 481 487
42. E. Solheim 1998 Growth factors in bone Int. Orthop. 22 410 416
43. T. J. Cho L. C. Gerstenfeld T. A. Einhorn 2002 Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing J. Bone Miner. Res. 17 513 520
44. S. Dedhar M. D. Mitchell M. D. Pierschbacher 1989 The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties Connect. Tissue Res. 20 49 61
45. P. A. Conget J. J. Minguell 1999 Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells J. Cell. Physiol. 181 67 73
46. J. S. Sun Y. H. Tsuang C. J. Liao H. C. Liu Y. S. Hang F. H. Lin 1997 The effects of calcium phosphate particles on the growth of osteoblasts J. Biomed. Mater. Res. 37 324 334